儿科骨髓母细胞瘤中的α/β值:辐射瘤学定制方法的含义
Danny Jazmati1,2, Dennis Sohn2, Juliane Hörner-Rieber1
1Department of Radiotherapy and Radiooncology, Medical Faculty, Heinrich Heine University, Moorenstr. 5, 40225, Dusseldorf, Germany.
Radiation oncology (London, England)
|January 29, 2025
概括
儿科骨髓母细胞瘤细胞系显示高的α/β比率,这表明正常或高分离放射治疗是最好的. 低分离放射治疗不建议用于儿童的治愈治疗.
科学领域:
- 辐射瘤学 辐射瘤学
- 儿科神经瘤学 儿童神经瘤学
- 放射生物学的放射生物学
背景情况:
- 脑髓母细胞瘤是最常见的儿科大脑瘤.
- 目前的治疗包括对3岁以上的儿童进行长达6周的脊辐射 (CSI).
- 辐射分离敏感性在成年人中得到了很好的研究,但在儿科脑髓母细胞瘤中未知.
研究的目的:
- 为了研究儿科骨髓母细胞瘤细胞系对不同辐射分化方案的放射敏感性.
- 为了确定儿科骨髓母细胞瘤细胞系的α/β值.
- 评估TP53状态和MYC表达对辐射敏感性的影响.
主要方法:
- 使用了五种儿科脑髓母细胞瘤细胞系 (ONS76,UW228-3,DAOY,D283,D425).
- 细胞暴露在不同的辐射剂量和分离方案中.
- 使用线性二次模型量化α/β值.
主要成果:
- 在多种脑髓母细胞瘤细胞系中观察到高的α/β比率 (平均11.01 Gy).
- TP53状态和MYC表达没有影响分离放射敏感性.
- 阿尔法/β值与分子子组或放射敏感性 (SF2) 不相关.
结论:
- 高的α/β值支持对儿科骨髓母细胞瘤进行常态分离或高分离放射治疗.
- 在这种人群中,不建议使用低分离放射治疗作为治愈方法.
- 这些发现使得对特定患者的儿科放射治疗的放射生物效应的估计成为可能.
更多相关视频
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
7.2K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.7K
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Biological Effects of Radiation
15.3K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
15.3K
